SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-16-075190
Filing Date
2016-01-11
Accepted
2016-01-11 17:58:43
Documents
1
Period of Report
2016-01-11

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v428800_4.html 4  
1 OWNERSHIP DOCUMENT v428800_4.xml 4 3060
  Complete submission text file 0001144204-16-075190.txt   4503
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Issuer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TITAN PHARMACEUTICALS, INC. 400 OYSTER POINT BLVD., STE 505 SAN FRANCISCO CA 94080
Business Address
Rubin Marc (Reporting) CIK: 0001412377 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-13341 | Film No.: 161337236